vs

Side-by-side financial comparison of HARROW, INC. (HROW) and LATTICE SEMICONDUCTOR CORP (LSCC). Click either name above to swap in a different company.

LATTICE SEMICONDUCTOR CORP is the larger business by last-quarter revenue ($145.8M vs $89.1M, roughly 1.6× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -5.2%, a 12.7% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 9.3%). LATTICE SEMICONDUCTOR CORP produced more free cash flow last quarter ($44.0M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 8.4%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Lattice Semiconductor Corporation is an American semiconductor company specializing in the design and manufacturing of low power field-programmable gate arrays (FPGAs). Headquartered in the Silicon Forest area of Hillsboro, Oregon, the company also has operations in San Jose, Calif., Shanghai, Manila, Penang, and Singapore. Lattice Semiconductor has more than 1000 employees and an annual revenue of more than $660 million as of 2022. The company was founded in 1983 and went public in 1989. It ...

HROW vs LSCC — Head-to-Head

Bigger by revenue
LSCC
LSCC
1.6× larger
LSCC
$145.8M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+24.0% gap
HROW
33.3%
9.3%
LSCC
Higher net margin
HROW
HROW
12.7% more per $
HROW
7.4%
-5.2%
LSCC
More free cash flow
LSCC
LSCC
$35.9M more FCF
LSCC
$44.0M
$8.1M
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
8.4%
LSCC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HROW
HROW
LSCC
LSCC
Revenue
$89.1M
$145.8M
Net Profit
$6.6M
$-7.6M
Gross Margin
79.3%
68.5%
Operating Margin
17.5%
30.7%
Net Margin
7.4%
-5.2%
Revenue YoY
33.3%
9.3%
Net Profit YoY
-2.2%
14.6%
EPS (diluted)
$0.20
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
LSCC
LSCC
Q1 26
$145.8M
Q4 25
$89.1M
Q3 25
$71.6M
$133.3M
Q2 25
$63.7M
$124.0M
Q1 25
$47.8M
$120.2M
Q4 24
$66.8M
$117.4M
Q3 24
$49.3M
$127.1M
Q2 24
$48.9M
$124.1M
Net Profit
HROW
HROW
LSCC
LSCC
Q1 26
$-7.6M
Q4 25
$6.6M
Q3 25
$1.0M
$2.8M
Q2 25
$5.0M
$2.9M
Q1 25
$-17.8M
$5.0M
Q4 24
$6.8M
$16.5M
Q3 24
$-4.2M
$7.2M
Q2 24
$-6.5M
$22.6M
Gross Margin
HROW
HROW
LSCC
LSCC
Q1 26
68.5%
Q4 25
79.3%
Q3 25
75.3%
67.9%
Q2 25
74.5%
68.4%
Q1 25
67.5%
68.0%
Q4 24
78.8%
61.1%
Q3 24
75.6%
69.0%
Q2 24
74.4%
68.3%
Operating Margin
HROW
HROW
LSCC
LSCC
Q1 26
0.7%
Q4 25
17.5%
Q3 25
20.6%
-1.2%
Q2 25
17.9%
3.8%
Q1 25
-23.5%
5.8%
Q4 24
19.3%
-10.4%
Q3 24
2.7%
5.9%
Q2 24
3.1%
18.2%
Net Margin
HROW
HROW
LSCC
LSCC
Q1 26
-5.2%
Q4 25
7.4%
Q3 25
1.4%
2.1%
Q2 25
7.8%
2.3%
Q1 25
-37.2%
4.2%
Q4 24
10.1%
14.1%
Q3 24
-8.6%
5.7%
Q2 24
-13.2%
18.2%
EPS (diluted)
HROW
HROW
LSCC
LSCC
Q1 26
$-0.06
Q4 25
$0.20
Q3 25
$0.03
$0.02
Q2 25
$0.13
$0.02
Q1 25
$-0.50
$0.04
Q4 24
$0.19
$0.12
Q3 24
$-0.12
$0.05
Q2 24
$-0.18
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
LSCC
LSCC
Cash + ST InvestmentsLiquidity on hand
$72.9M
$133.9M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$714.1M
Total Assets
$399.5M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
LSCC
LSCC
Q1 26
$133.9M
Q4 25
$72.9M
Q3 25
$74.3M
$117.9M
Q2 25
$53.0M
$107.2M
Q1 25
$66.7M
$127.6M
Q4 24
$47.2M
$136.3M
Q3 24
$72.6M
$124.3M
Q2 24
$71.0M
$109.2M
Total Debt
HROW
HROW
LSCC
LSCC
Q1 26
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Stockholders' Equity
HROW
HROW
LSCC
LSCC
Q1 26
$714.1M
Q4 25
$52.4M
Q3 25
$47.0M
$706.4M
Q2 25
$49.7M
$687.0M
Q1 25
$56.5M
$707.9M
Q4 24
$69.7M
$710.9M
Q3 24
$58.0M
$703.5M
Q2 24
$58.5M
$698.8M
Total Assets
HROW
HROW
LSCC
LSCC
Q1 26
$883.1M
Q4 25
$399.5M
Q3 25
$363.1M
$844.4M
Q2 25
$345.0M
$808.6M
Q1 25
$364.2M
$823.6M
Q4 24
$389.0M
$843.9M
Q3 24
$351.5M
$853.7M
Q2 24
$306.6M
$827.5M
Debt / Equity
HROW
HROW
LSCC
LSCC
Q1 26
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
LSCC
LSCC
Operating Cash FlowLast quarter
$8.4M
$57.6M
Free Cash FlowOCF − Capex
$8.1M
$44.0M
FCF MarginFCF / Revenue
9.1%
30.2%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$153.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
LSCC
LSCC
Q1 26
$57.6M
Q4 25
$8.4M
Q3 25
$16.6M
$47.1M
Q2 25
$-803.0K
$38.5M
Q1 25
$19.7M
$31.9M
Q4 24
$-17.8M
$45.4M
Q3 24
$3.0M
$44.0M
Q2 24
$-2.7M
$21.9M
Free Cash Flow
HROW
HROW
LSCC
LSCC
Q1 26
$44.0M
Q4 25
$8.1M
Q3 25
$16.4M
$34.0M
Q2 25
$-969.0K
$31.3M
Q1 25
$19.5M
$23.3M
Q4 24
$-18.3M
$39.7M
Q3 24
$2.3M
$39.4M
Q2 24
$-3.1M
$14.8M
FCF Margin
HROW
HROW
LSCC
LSCC
Q1 26
30.2%
Q4 25
9.1%
Q3 25
22.9%
25.5%
Q2 25
-1.5%
25.2%
Q1 25
40.8%
19.4%
Q4 24
-27.4%
33.8%
Q3 24
4.8%
31.0%
Q2 24
-6.3%
11.9%
Capex Intensity
HROW
HROW
LSCC
LSCC
Q1 26
9.3%
Q4 25
0.4%
Q3 25
0.3%
9.8%
Q2 25
0.3%
5.8%
Q1 25
0.4%
7.2%
Q4 24
0.8%
4.9%
Q3 24
1.2%
3.7%
Q2 24
0.7%
5.8%
Cash Conversion
HROW
HROW
LSCC
LSCC
Q1 26
Q4 25
1.27×
Q3 25
16.26×
16.86×
Q2 25
-0.16×
13.23×
Q1 25
6.35×
Q4 24
-2.62×
2.75×
Q3 24
6.12×
Q2 24
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons